NorthCrest Asset Manangement’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
NorthCrest Asset Manangement's LLY Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Eli Lilly (LLY) stake by 5.5% in Q2 2026, buying an estimated $926K and bringing the position to 17,429 shares worth $21.2M. The position accounts for 0.54% of the portfolio, ranked #41.
NorthCrest Asset Manangement first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $21.3M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- NorthCrest Asset Manangement held 17,429 shares of Eli Lilly worth $21.2M as of Q2 2026.
- NorthCrest Asset Manangement bought 906 Eli Lilly shares in Q2 2026, an estimated $926K.
- Eli Lilly made up 0.54% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #41 holding.
- NorthCrest Asset Manangement first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Eli Lilly position peaked at $21.3M in Q4 2025.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.